Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Luber

BG Medicine has appointed Jeffrey Luber to its board of directors. Luber replaces Noubar Afeyan, who resigned from the position. Since July 2014, Luber served as vice president of corporate development and general counsel for Good Start Genetics. Prior to that, he served as CEO of Exact Sciences, where he also served the company's president, CFO and treasurer, and general counsel.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.